Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer

COPENHAGEN, Denmark Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced the appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer, effective from January 2020.In this role, Mr. May will lead the establishment of the Bavarian Nordic commercial organization and manage the commercial business going forward. He will report to Paul Chaplin, President and CEO, and will join the Company’s Executive Management Team. Mr. May brings 25 years of experience from commercial roles within GSK and most recently served as Vice President and Global Vaccines Commercialization Leader at GSK where he was responsible for global strategic leadership and performance of several lifesaving vaccines, including Rabipur®/RabAvert® and Encepur®. Mr. May is Doctor of Pharmacy from University of Lille II and holds an MBA from HEC Paris.
“I am delighted to welcome Jean-Christophe to Bavarian Nordic. He brings a wealth of commercial experience to the Company and will be an invaluable addition to the Executive Management team. He even brings significant knowledge and experience related to Rabipur/RabAvert and Encepur and his proven track record in life sciences and international business will be invaluable to us as we establish and grow our commercial franchise,” said Paul Chaplin, President and CEO of Bavarian Nordic.